7,511.12

-38.82

-0.51%

52,197.12

-192.63

-0.37%

25,008.50

-244.64

-0.97%

2,817.69

-23.12

-0.81%

4.9810

+0.1170

+2.40%

19.97

+0.05

+0.25%

4,035.60

-78.90

-1.92%

73,376.69

-1,383.16

-1.85%

Crude Oil Dec 26

86.38

-0.47

-0.54%

US Private Equity

10,850.15

0.00

0.00%

NasdaqCM - Nasdaq Real Time Price USD

Acurx Pharmaceuticals, Inc. (ACXP)

1.0500 -0.0100 (-0.94%)

As of 3:03:59 PM EST. Market Open.

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Acurx Pharmaceuticals Inc (ACXP) (Q2 2026) Earnings Call Highlights: FDA Signals Potential ...

GuruFocus.com 2mo ago

ACXP
-0.94%
Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's Why

Zacks 5mo ago

ACXP
-0.94%
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?

Zacks 9mo ago

ACXP
-0.94%
ADIL
Acurx Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary

Moby 2mo ago

NVDA

ACXP
-0.94%
Is Acurx Pharmaceuticals (ACXP) Stock Outpacing Its Medical Peers This Year?

Zacks 7mo ago

ACXP
-0.94%
Acurx Pharmaceuticals Inc (ACXP) Q4 2025 Earnings Call Highlights: Financial Growth and ...

GuruFocus.com 7mo ago

ACXP
-0.94%
Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect?

Zacks 7mo ago

ACXP
-0.94%
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?

Zacks 7mo ago

ACXP
-0.94%
BC-Most Active Stocks

Associated Press Finance 7mo ago

ASNS

^IXIC

KALA
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors

Insider Monkey 8mo ago

ACXP
-0.94%
Loss-Making Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Expected To Breakeven In The Medium-Term

Simply Wall St. 9mo ago

ACXP
-0.94%

Performance Overview

Return	ACXP	S&P 500 (^GSPC)
YTD	-57.63%	+9.75%
1-Year	-79.90%	+9.96%
3-Year	-98.63%	+70.16%

Mobilize your Website

View Site in Mobile | Classic

Share by: